A Study Protocol for Increasing Access to Smoking Cessation Treatments for Low-Income Minority Smokers.
A Study Protocol for Increasing Access to Smoking Cessation Treatments for Low-Income Minority Smokers.
复制标题
DOI：
10.3389/fpubh.2021.762784
复制
发表时间：
2021
影响因子：
5.2
通讯作者：
Winn R
中科院分区：
文献类型：
--
作者：
Matthews AK;Watson KS;Duang C;Steffen A;Winn R
背景：低收入患者的吸烟率是普通人群的两倍。获得医疗保健是健康的一个重要社会决定因素。联邦合格的医疗保健中心(FQHC)是政府支持的、以社区为基础的中心，旨在增加未参保和保险不足患者获得医疗保健的机会。然而，实施障碍影响了在FQHC环境下循证戒烟的坚持和可持续性。为了解决这一实施障碍，我们的多学科团队提出了小米戒烟护理(Mile Square Quit Community-Access-Referral-Expansion)，以建立FQHC系统的可接受性、可行性和能力，以提供基于证据的多层次干预，以增加患者对州烟草戒烟线的参与度。方法：混合方法的方法，根植于RE-AIM(REACH，有效性，采用，实施和维护)的实施科学框架，将在这一混合有效性-实施设计中使用。我们的目标是评估一种新的传递系统(患者门户)在增加戒烟治疗机会方面的有效性。为了准备未来的Mi戒烟护理随机临床试验，我们将进行以下开发研究：(1)检查我们的合作伙伴FQHC服务的患者群体中的烟草负担，(2)评估FQHC患者和医疗保健提供者中与戒烟相关的知识、态度、障碍和促进者以及我们的干预组件，(3)评估使用定制的沟通策略和患者导航来增加患者对患者门户网站的接受，以及(4)测试合作伙伴FQHC提供Mi戒烟护理的可接受性、可行性和能力。讨论：本研究为开发和实施通过患者健康门户网站为低收入患者提供的吸烟和其他健康促进干预措施提供了一个模式。如果成功，这项干预将对解决癌症和其他烟草相关疾病的关键社会决定因素产生重要影响。试验注册：美国国立卫生研究院临床试验，NCT04827420，https://clinicaltrials.gov/ct2/show/NCT04827420.
Background: Smoking rates among low-income patients are double those of the general population. Access to health care is an essential social determinant of health. Federally qualified health care centers (FQHC) are government-supported and community-based centers to increase access to health care for non-insured and underinsured patients. However, barriers to implementation impact adherence and sustainability of evidence-based smoking cessation within FQHC settings. To address this implementation barrier, our multi-disciplinary team proposes Mi QUIT CARE (Mile Square QUIT Community-Access-Referral-Expansion) to establish the acceptability, feasibility, and capacity of an FQHC system to deliver an evidence-based and multi-level intervention to increase patient engagement with a state tobacco quitline. Methods: A mixed-method approach, rooted in an implementation science framework of RE-AIM (Reach, Effectiveness, Adoption, Implementation, and Maintenance), will be used in this hybrid effectiveness-implementation design. We aim to evaluate the efficacy of a novel delivery system (patient portal) for increasing access to smoking cessation treatment. In preparation for a future randomized clinical trial of Mi QUIT CARE, we will conduct the following developmental research: (1) Examine the burden of tobacco among patient populations served by our partner FQHC, (2) Evaluate among FQHC patients and health care providers, knowledge, attitudes, barriers, and facilitators related to smoking cessation and our intervention components, (3) Evaluate the use of tailored communication strategies and patient navigation to increase patient portal uptake among patients, and (4) To test the acceptability, feasibility, and capacity of the partner FQHC to deliver Mi QUIT CARE. Discussion: This study provides a model for developing and implementing smoking and other health promotion interventions for low-income patients delivered via patient health portals. If successful, the intervention has important implications for addressing a critical social determinant of cancer and other tobacco-related morbidities. Trial Registration: U.S. National Institutes of Health Clinical Trials, NCT04827420, https://clinicaltrials.gov/ct2/show/NCT04827420.
登录
查看更多内容
影响因子：
12.7
作者：
Glasgow, RE;Vogt, TM;Boles, SM
通讯作者：
Boles, SM
DOI：
10.1016/0749-5978(91)90020-t
发表时间：
1991-12-01
影响因子：
4.6
作者：
AJZEN, I
通讯作者：
AJZEN, I
影响因子：
5.5
作者：
Flocke SA;Hoffman R;Eberth JM;Park H;Birkby G;Trapl E;Zeliadt S
通讯作者：
Zeliadt S
影响因子：
4.4
作者：
Krist, Alex H.;Woolf, Steven H.;Cohn, Jeffrey
通讯作者：
Cohn, Jeffrey
影响因子：
39
作者：
Fu, Steven S.;van Ryn, Michelle;Joseph, Anne M.
通讯作者：
Joseph, Anne M.